Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Revenue from awards $ 1,762,059 $ 1,885,682
Operating expenses:    
Research and development 23,947,866 21,783,704
General and administrative 7,699,479 6,624,747
Total operating expenses 31,647,345 28,408,451
Operating loss (29,885,286) (26,522,769)
Other income (expense):    
Interest income, net 101,993 334,595
Foreign currency exchange gain (loss), net 126,493 (46,635)
Other income, net 228,486 287,960
Net loss $ (29,656,800) $ (26,234,809)
Net loss per share, basic and diluted $ (0.43) $ (0.43)
Weighted average number of common shares outstanding, basic and diluted 69,272,402 61,675,904